1. Home
  2. NWTG vs APVO Comparison

NWTG vs APVO Comparison

Compare NWTG & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newton Golf Company Inc.

NWTG

Newton Golf Company Inc.

HOLD

Current Price

$1.27

Market Cap

4.8M

ML Signal

HOLD

Logo Aptevo Therapeutics Inc.

APVO

Aptevo Therapeutics Inc.

HOLD

Current Price

$1.70

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NWTG
APVO
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.3M
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
NWTG
APVO
Price
$1.27
$1.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.7K
96.1K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
99.09
0.13
EPS
N/A
N/A
Revenue
$8,135,000.00
$3,114,000.00
Revenue This Year
$53.21
N/A
Revenue Next Year
$40.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
136.14
N/A
52 Week Low
$0.70
$0.50
52 Week High
$2.07
$10.70

Technical Indicators

Market Signals
Indicator
NWTG
APVO
Relative Strength Index (RSI) 54.23 23.32
Support Level $0.97 $0.50
Resistance Level $1.44 $4.84
Average True Range (ATR) 0.10 0.22
MACD -0.02 -0.01
Stochastic Oscillator 35.29 5.29

Price Performance

Historical Comparison
NWTG
APVO

About NWTG Newton Golf Company Inc.

Newton Golf Co Inc is a technology-forward golf company engaged in designing, manufacturing, and selling performance golf equipment, including premium golf shafts and putters, and focuses on developing technology-driven golf products intended to enhance player performance. The company sells its products through e-commerce, distributors, wholesale customers, including pro-shops at golf courses and off-course retailers, sporting goods retailers, online retailers, third-party distributors, and through Club Champion Golf.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, CD3xCD123, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: